PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
411.29%
Net income growth above 1.5x META's 16.87%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-1.97%
Negative yoy D&A while META is 11.25%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-212.50%
Negative yoy deferred tax while META stands at 79.11%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
33.03%
SBC growth well above META's 17.32%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-88.58%
Both reduce yoy usage, with META at -48.49%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
155.76%
AR growth well above META's 157.35%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-167.71%
Both reduce yoy inventory, with META at -93.21%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-81.87%
Both negative yoy AP, with META at -98.00%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-90.13%
Both reduce yoy usage, with META at -93.35%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-4612.50%
Negative yoy while META is 60.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
13.38%
Operating cash flow growth above 1.5x META's 2.48%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-69.47%
Both yoy lines negative, with META at -24.31%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-8828.57%
Both yoy lines negative, with META at -188.24%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
36.10%
Purchases well above META's 23.71%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-15.74%
We reduce yoy sales while META is 119.06%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
66.67%
We have some outflow growth while META is negative at -133.33%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-12.50%
We reduce yoy invests while META stands at 74.22%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-109.16%
We cut debt repayment yoy while META is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-3.43%
Both yoy lines negative, with META at -85.18%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.